A first-in-human, first-in-class, phase (ph) I study of systemic Hedgehog (Hh) pathway antagonist, GDC-0449, in patients (pts) with advanced solid tumors
暂无分享,去创建一个
C. Rudin | M. Borad | P. LoRusso | J. Low | F. Sauvage | L. Vernillet | H. Mackey | J. Dimartino | W. Darbonne | D. V. Hoff